Navigation Links
Watson Presents Outlook for Continued Long Term Growth
Date:1/21/2011

r RAPAFLO® treatment for benign prostatic hyperplasia (BPH), GELNIQUE® treatment for overactive bladder (OAB), and ANDRODERM® and AndroGel® testosterone replacement therapies," said Wilkinson.  "We expanded our Womens Health franchise with the approval of ella®, our emergency contraceptive, the acquisition of Crinone® for the treatment of infertility, and the end-of-year approval of our novel oral contraceptive.  We also added a new product for the treatment of uterine fibroids to our development pipeline, and licensed and began development of our first biologic product."

"The most exciting milestone achieved during 2010 was the completion of the Phase III PREGNANT study of Prochieve® for the prevention of preterm birth," Wilkinson noted.  "Preterm birth represents a significant unmet medical need, and the clinical study data demonstrates a significant reduction in preterm birth at multiple time frames.  Results also indicated an improvement in infant outcomes.  We are preparing for the publication of the full clinical trials in the first quarter of 2011, and anticipate filing our New Drug Application (NDA) in the second quarter of 2011.  It is our goal to establish Prochieve® as the recommended treatment of choice for pregnant women with a short cervix."  

"We enter 2011 with an expanding womens health portfolio, a strong pipeline of products in the U.S., and we are implementing a strategy to expand our business into Canada, Latin America and Europe."

2010 Global Brands revenue is expected to be $400 million, and the Company expects 2011 Global Brands segment revenue of between $470 and $490 million, reflecting continued growth of its current promoted products, as well as the launch of new brand products into the U.S. market during the year.

Global OperationsRobert Stewart, Watson's Executive Vice President, Global Operations told analysts, "In 2010 we made tre
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Reportlinker Adds Watson Pharmaceuticals Inc.: PharmaVitae Profile
2. Watson Announces Preliminary Financial Performance for FY 2010
3. Watson to Host Investor Day on January 21 in New York City
4. Watsons Generic Fentora® Receives FDA Approval
5. Watson to Present at the 29th Annual JP Morgan Healthcare Conference
6. Watson Announces Novel Oral Contraceptive Approval
7. Watson and Richter Announce Exclusive License Agreement for Esmya™
8. Watson Confirms Exalgo™ Patent Challenge
9. Watson Announces Pricing of Secondary Offering By Selling Stockholder
10. Watson Announces Commencement of Secondary Offering by Selling Stockholder
11. Watson To Present At The 2010 Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)...  Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... conferences during the third quarter, the 2014 Avondale Partners ... 2014 Conference.  Alexza,s corporate presentation will be webcast live ... event are below: , 2014 Avondale Partners ... Boston , MA.  The format is limited ...
(Date:7/29/2014)... ROCKVILLE, Md. , July 29, 2014  Synthetic ... anti-infective biologic and drug candidates targeting specific pathogens that ... view of the unusual market activity in the Company,s ... Company in accordance with its usual practice. The Company ... unusual market activity. About Synthetic Biologics, Inc. ...
(Date:7/29/2014)... Conn. , July 29, 2014 Numotion,s Board ... Mike Swinford will be the company,s new Chief ... highly successful 22-year career at GE where he worked primarily ... in annual revenue to over $5 billion. His most recent ... Services. "I am thrilled to join Numotion," ...
Breaking Medicine Technology:Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 2Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 3Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity 2Numotion Names Mike Swinford CEO 2
(Date:7/29/2014)... survivors of severe combat injuries threatening more than one ... good record of safety and effectiveness in avoiding amputation, ... Plastic and Reconstructive Surgery , the official ... Surgeons (ASPS). , Experience with multiple limb salvage ... good success rates, with no increase in complications compared ...
(Date:7/29/2014)... 29, 2014 (HealthDay News) -- Chlorine helps keep pool ... likely to develop eye infections, doctors say. ... well as blurry vision, said Dr. Sampson Davis, an ... New Jersey. It,s important to understand why this ... away the outer film layer of the eye that ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 According to ... of Time Magazine titled “From Kim’s Butt to Angelina’s ... Kardashian’s butt is the celebrity feature most requested ... features include Beyoncé’s butt, Jennifer Lawrence’s nose, ... information is based on data collected by an online ...
(Date:7/29/2014)... County, NJ (PRWEB) July 29, 2014 ... two leading pediatricians have joined our network, CarePoint ... Politis and Dr. Sushma Kaki. Hundreds of highly ... Group, a comprehensive network of top doctors and ... of specialties. This latest acquisition represents CarePoint Health’s ...
(Date:7/29/2014)... New high priced hepatitis C drugs will ... projected $2.9 to $5.8 billion next year, according to ... today by the Pharmaceutical Care Management Association (PCMA). Milliman ... as much as 8.6 percent in 2015 as a ... Olysio. , The study finds that the majority of ...
Breaking Medicine News(10 mins):Health News:Good outcomes with multiple limb salvage after severe combat injuries, reports Plastic and Reconstructive Surgery 2Health News:Protect Your Eyes When Hitting the Pool 2Health News:Celebrity Plastic Surgery: Kim Kardashian’s Butt Tops the List of Celebrity Plastic Surgery Requests 2Health News:Dr. Politis and Dr. Kaki Join CarePoint Health Medical Group 2Health News:Dr. Politis and Dr. Kaki Join CarePoint Health Medical Group 3Health News:New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2
... , , Diverse Donors Make the Difference ... National Minority Donor Awareness Day is August 1, and New York Blood Center ... New Jersey call on the community to help us meet the great need ... Historically, National Minority Donor Awareness Day emphasized minority organ and tissue donation, ...
... , , WASHINGTON, July 23 The ... recognized strategist in public health and science policy, as its president. , ... ) , , Lappin, an attorney, ... leading a major patient advocacy organization and serving as a senior advisor ...
... study led by researchers at the Ohio State University ... late-stage, hormone-independent prostate tumors gain the ability to grow ... growth marks an advanced and currently incurable stage of ... 2009, issue of the journal Cell , focuses ...
... 23, 2009 Case Western Reserve University School of Medicine ... Institutes of Health to determine if painful bladder syndrome ... system rather than in the bladder itself. ... M.D., professor of neurology at the Case Western Reserve ...
... the rapid growth in health care costs in the ... industries that commonly provide workers with health insurance. ... from 1987 through 2005 and compared changes in employment, ... gross domestic product for industries where a large number ...
... , FORT WORTH, Texas and AUSTIN, Texas, ... to announce a partnership with seven-time Tour de France winner Lance Armstrong ... Lance Armstrong will compete for Team RadioShack as a cyclist, runner and ... , , Lance Armstrong returned to the ...
Cached Medicine News:Health News:The Gift of Life Flows Through Your Veins! 2Health News:The Gift of Life Flows Through Your Veins! 3Health News:Council for American Medical Innovation Names Debra R. Lappin President 2Health News:Council for American Medical Innovation Names Debra R. Lappin President 3Health News:Scientists discover key event in prostate cancer progression 2Health News:Case Western Reserve University receives $3.7M NIH grant to study autonomic nervous system link to painful bladder syndrome 2Health News:Study finds rapid growth in health costs hurts economic performance of US industries 2Health News:Study finds rapid growth in health costs hurts economic performance of US industries 3Health News:RadioShack Partners With Seven-Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 2Health News:RadioShack Partners With Seven-Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 3Health News:RadioShack Partners With Seven-Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 4
Kevorkian Collector Endocervical Curette is a stainless-steel curette with rounded tip....
Available in 5, 8 and 12 mm bite, with and without teeth....
...
...
Medicine Products: